Abstract
To achieve the use of this genetic material you have to have several aspects in mind. First, it is necessary to define what is the DNA sequence that is going to be inserted into the patient's body. In these cases, it depends a lot on the disease that is trying to be cured. For example, in the case of Hemophilia type B, the gene that deals is that which produces factor IX [3]. Second, once the gene is well identified, a vehicle is occupied to transport it to the desired cells. Returning to the example of Hemophilia, we would occupy a vector or vehicle, viral or non-viral, to transport the gene to the liver cells responsible for the production of factor IX. Each of these two categories has its pros and cons
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The authors keep the copyright and publication rights in the journal the right of the first publication and this possibility to edit, reproduce, distribute, expose and publicly communicate on the magazine's website. Likewise, it assumes the commitment on any litigation or claim related to the rights of intellectual property, exonerating of responsibility to the Science and Health Magazine of the UCIMED. In addition, you can see how they are published in this journal (eg, Include in an institutional repository or publish it in a book) as long as they clearly indicate the work published for the first time in the magazine Science and Health of the UCIMED.